Eliem Therapeutics Stock (NASDAQ: ELYM) stock price, news, charts, stock research, profile.
Open | $8.090 |
Close | $7.840 |
Volume / Avg. | 38.629K / 871.963K |
Day Range | 7.670 - 8.180 |
52 Wk Range | 2.340 - 11.550 |
Market Cap | $240.002M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 0.55% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eliem Therapeutics (NASDAQ: ELYM) through any online brokerage.
Other companies in Eliem Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Agenus (NASDAQ:AGEN), Monte Rosa Therapeutics (NASDAQ:GLUE), Century Therapeutics (NASDAQ:IPSC) and Design Therapeutics (NASDAQ:DSGN).
The latest price target for Eliem Therapeutics (NASDAQ: ELYM) was reported by HC Wainwright & Co. on Wednesday, March 8, 2023. The analyst firm set a price target for 6.00 expecting ELYM to fall to within 12 months (a possible -27.27% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $8.25 last updated May 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Eliem Therapeutics.
Eliem Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Eliem Therapeutics.
Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.